what is the new industry being started for marijuana that has been green lighted by June 25th that Ernie Trembly is speaking aboutthat could turn 5 companies he is watching into over 2 million in profits as it is used medicinally in quantities much larger than those used for recreational use. The pharmaceutical side will increase use to over 1 trillion dollars . Epidialex(sp) is the first of FDA drugs approved for use. Travis any ideas what these companies might be? Thanks !
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
It just refering to mostly the well established bio tech marijuana stocks now that gw phar has a cannabis based product threw the fda the companies he teased including insy are nothing spectacular if u are involved with the marijuana game none of these are worth throwing money their way away from the better marijuana stock available
Hi backoffice,
Let me give you my best guess on the 5 companies touted by Tremblay’s Bio Insider Alert. I am quoting brief summaries of the companies from the teaser and then give my guess.
1. Cannabis’s New Solution for Pain: See how this tiny $1 stock’s discovery could end the opioid addiction crisis and hand you 8,300% gains.
That’s probably Emblem Corp. (EMC.V/EMMBF). Lots of companies try to develop cannabinoid painkillers, but Emblem has the involvement of one of the scientists who “brought OxyContin to the U.S. market”, as the teaser claims.
2. The GvHD Orphan Drug: It’s the first ever life-saving treatment for transplant patients that’s Cannabis-based. The target here is a 90-to-1 windfall
That’s most likely Mesoblast Lt. (MESO/MSB.ASX)
3. The First Ever “Fragile X” Treatment: This little company is bringing hope to thousands of children worldwide. With the FDA already granting orphan drug status, 59-fold growth is within reach.
That’s most likely Zynerba Pharmaceuticals (ZYNE).
4. The New “Cannabis Drug Super Machine”: The proprietary BioInformatics this company holds could cut drug discovery time in half and bring you 34,800% profits.
Most likely InMed Pharmaceuticals (IMLFF).
5. The Long-Awaited Treatment for Tourette’s: Phase 2 results are being prepared for release soon. So you’ll want to get in early for your chance to pocket a 351-to-1 windfall.
That’s the hardest one for me. Neurocrine Biosciences (NBIX) is the best know player in that space, but they don’t seem to do cannbinoids. So it’s probably Therapix (TRPX).
I could elaborate more on the pro and cons of each selection, but the comment is already getting pretty long. Does anyone have a different hunch?